NYSEARCA:LABU Direxion Daily S&P Biotech Bull 3x Shares (LABU) Price, Holdings, & News $94.24 +4.45 (+4.96%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatings About Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get LABU alerts:Sign Up Key Stats Today's Range$88.40▼$96.1150-Day Range$89.79▼$146.9652-Week Range$80.41▼$176.99Volume1.29 million shsAverage Volume1.89 million shsMarket Capitalization$981.98 millionAssets Under Management$682.63 millionDividend Yield0.59%Net Expense Ratio0.96%Aggregate RatingModerate Buy ETF OverviewThe Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.Read More… Direxion Daily S&P Biotech Bull 3x Shares ExpensesTypeLABUHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.57%0.55%0.51%0.52%Other Expenses0.21%0.30%0.49%0.57%0.53%Total Expense0.96%0.70%0.71%0.73%0.71%Fee Waiver0.00%-0.45%-0.51%-0.67%-0.56%Net Expense0.96%0.61%0.61%0.58%0.59% Receive LABU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bull 3x Shares and its competitors with MarketBeat's FREE daily newsletter. Email Address LABU ETF News HeadlinesULTY: ~74% Trailing Yield, But Look Out BelowOctober 11, 2024 | seekingalpha.comDirexion Daily S&P 500 Bull 3X Shares declares quarterly distribution of $0.3367September 24, 2024 | msn.comThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… December 22, 2024 | Crypto 101 Media (Ad)Direxion Daily S&P Biotech Bull 3X Shares declares quarterly distribution of $0.1502September 24, 2024 | msn.comDirexion Daily FTSE Europe Bull 3X Shares (EURL)May 17, 2024 | investing.comThe 3 Best Leveraged ETFs for April 2024April 2, 2024 | investorplace.comSee More Headlines LABU ETF - Frequently Asked Questions How have LABU shares performed this year? Direxion Daily S&P Biotech Bull 3x Shares' stock was trading at $121.97 at the start of the year. Since then, LABU stock has decreased by 22.7% and is now trading at $94.24. View the best growth stocks for 2024 here. When did Direxion Daily S&P Biotech Bull 3x Shares' stock split? Direxion Daily S&P Biotech Bull 3x Shares shares reverse split on Monday, December 4th 2023. The 1-20 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Direxion Daily S&P Biotech Bull 3x Shares' major shareholders? Direxion Daily S&P Biotech Bull 3x Shares' top institutional shareholders include Tidal Investments LLC (0.67%), Jane Street Group LLC, TB Alternative Assets Ltd. (0.40%) and Wolverine Trading LLC. How do I buy shares of Direxion Daily S&P Biotech Bull 3x Shares? Shares of LABU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Direxion Daily S&P Biotech Bull 3x Shares own? Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bull 3x Shares investors own include Micron Technology (MU), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), AT&T (T), Direxion Daily Semiconductors Bull 3x Shares (SOXL) and Advanced Micro Devices (AMD). Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bull 3x Shares Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABU Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings169 Fund Statistics Assets Under Management$682.63 million Average Daily Volume$1.19 million Discount/Premium0.22% Leveraged3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume8,327 Put Options3,322 Call Options5,005 Short Interest702,800 shs Miscellaneous Outstanding Shares10,420,000Beta3.31 Creation Unit50,000 Creation Fee$250.00 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Top 10 LABU HoldingsS&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 61.62%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 43.60%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 35.50%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 29.31%DREYFUS GOVT CASH MAN INSHolding Weight: 28.83%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 26.76%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 24.20%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 18.73%GOLDMAN FINL SQ TRSRY INST 506Holding Weight: 9.93%Natera (NASDAQ:NTRA)Holding Weight: 2.04%Full Holdings DetailsLABU Sector ExposureLABU Industry Exposure This page (NYSEARCA:LABU) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
